Are you new to ctDNA testing strategies? Fear not! With this walk-through, we will guide you through some high-level concepts to help orient yourself in the current clinical landscape.
Vessel Tutorial - Understanding liquid biopsy results is highly dependent on tumor fraction of the cell-free DNA sample. Without information about ctDNA content from plasma, variant allele frequencies and uninformative testing results are very difficult to interpret.
Tissue and circulating tumor DNA testing can detect cancer alterations, but discrepancies in results can impact treatment decisions. This briefing discusses the basics and presents case studies.
You’ve successfully subscribed to Vessel
Welcome back! You’ve successfully signed in.
Great! You’ve successfully signed up.
Success! Your email is updated.
Your link has expired
Success! Check your email for magic link to sign-in.
